Mirna Therapeutics and UCSF sign collaboration agreement
The collaboration will include studies of cancer-related microRNAs that were discovered at both Mirna and University of California, San Francisco (UCSF) as well as small RNAs that will
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
CyDex has an international patent cooperation treaty application pending for this combination nasal spray product. A randomized, double-blind, placebo-controlled, three-way cross-over study was conducted in 108 seasonal allergic